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ABSTRACT 
 
TRAVER, SAMANTHA L. Development of a robust genetic test for hyperkalemic  
periodic paralysis (HYPP) in quarter horses. Department of  
Biological Sciences, June 2011.  
 
 
A single nucleotide substitution in a region of the skeletal muscle sodium 
channel gene (SCN4A) is known to cause an equine genetic disorder known as 
Hyperkalemic Periodic Paralysis (HYPP). The clinical effects of this disorder range 
from little or no symptoms to frequent episodes of muscle tremors, weakness, and/or 
complete collapse. Oligonucleotide primer pairs were designed for both the wild type 
and mutant alleles of the SCN4A gene for use in Amplification Refractory Mutation 
System-PCR (ARMS-PCR). These primers were tested with genomic DNA isolated 
from whole blood, saliva swabs, and hair of individual horses. It was determined that 
horse hair represented the most easily obtainable and reliable source for genomic 
DNA isolation.  DNA was isolated from the hair of unaffected (wild-type) horses 
(N/N), a carrier for HYPP (N/H) and a homozygous mutant for the disease (H/H). As 
expected for the unaffected individual, a PCR product using the wild type-specific 
primer pair was generated, while the mutant-specific primer pair did not produce a 
product. DNA isolated from HYPP animals produced a PCR product with only the 
mutant-specific primer pair, and the carriers for HYPP produced a product in both 
wild type and mutant-specific PCR reactions.  This robust DNA-based test was 
shown to generate an unambiguous assignment of the genetic status of the horses 
tested with respect to the HYPP trait. 
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INTRODUCTION 
 
 In March of 2007 the DNA sequence of the horse (Equus ferus caballus) 
genome became available to public databases, which provided ample opportunities 
for scientific and genetic researchers (Chowdhary and Raudsepp, 2004).  Specifically, 
genetic diseases could now be more closely investigated and specific mutations could 
be identified and connected to such diseases.  The breeding of horses is highly 
regulated among various breeds, and bloodlines are often diligently recorded and 
traced by breeders with hopes to produce the most optimal and successful offspring. 
Along with desirable characteristics being passed down through the lineages, genetic 
mutations manifest themselves the same way. With the sequencing of the horse 
genome and identification of certain mutations, this pattern of proliferation of genetic 
diseases can now be characterized and diagnostic tests can be provided to detect 
mutations in individual horses. If these mutations could be detected, the tendency to 
breed affected individuals could be reduced as a result, thus lowering the percentage 
of affected offspring and eventually decreasing the prevalence of certain harmful 
genetic diseases in the equine population.    
 
HYPP Genotype 
 
Hyperkalemic Periodic Paralysis (HYPP) is an autosomal dominant genetic 
disease that affects approximately 4% of all Quarter Horses (Spier, 2006). The disease 
is caused by a single nucleotide polymorphism (SNP), or substitution of cytosine to 
guanine in the skeletal muscle sodium channel gene (SCN4A) (Rudolph et al., 1992).  
This mutation is found at position 14,273,176 on chromosome 11 (Rudolph et al., 
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1992) and results in an amino acid substitution of phenylalanine to leucine in the 
SCN4A protein product. This substitution causes a conformational change in the 
sodium ion channel, thus leading to symptoms of varying severity regarding ion 
regulation, including that of potassium. The genetic mutation has been traced back to 
one individual, a Quarter Horse stallion called Impressive, who was a carrier of 
HYPP and was born in 1968.  This particular stallion was highly bred due to his 
stunning conformation and muscle configuration (Finno et al., 2009). HYPP statuses 
are denoted by abbreviations, as shown in Table 1 below.  
 
HYPP Status Genotype Abbreviation 
Affected Homozygous for the mutant allele  HH 
Carrier Heterozygous for the mutant allele NH 
Wild-Type Homozygous for the wild-type allele NN 
Table 1: Abbreviations for HYPP statuses and genotypes that will be used throughout this paper.  
 
HYPP Phenotype 
 
 Clinical signs of HYPP can range from little or no symptoms to frequent 
episodes of muscle tremors, weakness, and/or complete collapse, often following a 
period of exercise (Spier, 2006). These episodes are caused by fluctuation of 
potassium levels in the blood that causes reactions of varying severity within the 
muscle (Spier, 2006).  Many descendants of Impressive who are carriers of this 
genetic disease seem to have also inherited Impressive’s physical characteristics such 
as defined muscle mass and attractive conformation, both of which are desirable traits 
in the halter-horse show industry.  However, when two carrier individuals are bred, 
approximately one quarter of their progeny will have HYPP. A picture of 
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Impressive’s well defined muscle mass and desirable conformation is shown in 
Figure 1 below.  
 
Figure 1: HYPP carrier Impressive, 
born 1968, who was highly bred due 
to his desirable physical 
characteristics for halter show horse 
breeding and showing, such as 
defined muscle mass and correct 
conformation. 
(http://crazyladyappaloosas.com/images/impres
siveside.jpg) 
 
 
 
 
 
In the past, it was felt that the positive attributes of the carrier phenotype 
outweighed the risk of progeny having HYPP, and halter-horse show breeders sought 
out Impressive descendents.  The negative attributes of HYPP seemed less significant 
to this particular industry since exercise is not necessary in halter-horse classes, so the 
episodes of HYPP would not affect the score and placement of the horse when being 
judged.  In everyday life, however, the clinical signs and symptoms of HYPP are still 
very prevalent and very dangerous. In 1998 the American Quarter Horse Association 
(AQHA) recognized the negative affects of perpetuating the mutant allele, and made 
genetic testing mandatory for registration if the horses were descendents of 
Impressive (Spier, 2006). An increase in the use of genetic testing for HYPP carriers 
and selective breeding of only “clear” individuals could eventually eradicate the 
disease from the breed. 
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Amplification Refractory Mutation System - Polymerase Chain Reaction 
 
 Polymerase Chain Reaction (PCR) is a widely used experimental technique, in 
which one can amplify regions of genomic DNA, or replicate a specific sequence of 
the original DNA template to create a large number of copies of that sequence or gene 
of interest. The process begins by the denaturing of a starting DNA template. Primers, 
or short strands of DNA sequences then anneal to the single stranded DNA and a 
DNA polymerase builds a new strand, using the original DNA as its template. This 
cycle occurs in fluctuating temperatures and repeats several times until the original 
DNA has been turned into hundreds of thousands of copies (Mullis et al., 1989). 
 Amplification Refractory Mutation System- PCR (ARMS-PCR) can be used 
to identify single nucleotide polymorphisms, or different allelic genotypes by creating 
nucleotide-specific primer pairs for both the wild type and mutant alleles for a 
specific gene (Newton et al., 1989). ARMS-PCR differs from general PCR in the 
generation of primers as well as the analysis of gel electrophoresis. With this 
technique, two PCR reactions are run with one genomic DNA sample; one with the 
wild-type specific primer pair and one with the mutant specific primer pair.  The two 
primer pairs have a common downstream primer, and the upstream primers differ by 
the penultimate, or second to last nucleotide in the primer and the final nucleotide, or 
the nucleotide that varies between the wild-type and mutant allele of the gene (Ye et 
al., 2001). This concept is shown below in Figure 2. The wild-type primer 
corresponds to the wild-type nucleotide at the site of the mutation in the genome, 
while the mutant primer corresponds to the mutated nucleotide at that position. Along 
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with this allelic specificity of the final nucleotide, changing the penultimate position 
is also important to ARMS-PCR to increase the instability of each primer pair to the 
DNA template (Ye et al., 2001). This helps to ensure that the wild-type primer pair 
only anneals to and produces a band with a wild-type allele and the mutant primer 
pair only anneals to and produces a band with a mutant allele. The use of both primer 
pairs in two separate PCR reactions allows for the identification of differing alleles of 
certain genes containing a single nucleotide polymorphism.  
 
 
Figure 2: Variation of the penultimate, or second to last nucleotide increases the specificity of the two 
reactions. For example, wild type DNA templates still anneal accurately to wild type specific primer 
pairs because of the accurate pairing of the final nucleotide, while the mismatch of the penultimate 
nucleotide of the mutant primer would cause destabilization and yield a negative product, as 
anticipated. Thus, only wild type specific primer pairs anneal to wild type templates and only mutant 
specific primer pairs anneal to mutant templates.  
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Experimental Goals 
 
 Although there is currently a working diagnostic test for HYPP, the goal of 
this project was to create a different efficient, robust, and unambiguous DNA-based 
test for this disease. With multiple efficient and cost effective tests in conjunction 
with the new AQHA registration guidelines, breeders will be more likely to test their 
animals and selectively breed them, allowing for the eventual eradication of the 
disease.  The current test involves PCR reactions that amplify a section of DNA that 
includes the cytosine to guanine substitution (Rudolph et al., 1992). These PCR 
reactions are then followed by allele-specific oligonucleotide hybridizations.  
Analysis of these allele-specific hybridization reactions can determine which alleles 
the genomic DNA sample contained, depending on which oligonucleotide probe the 
PCR products bound to, thus providing the HYPP status of the individual (Rudolph et 
al., 1992).  
 By using ARMS-PCR for my diagnostic test, the allele specificity lies within 
the PCR primers themselves, thus avoiding the need for oligonucleotide 
hybridization. The goal was to develop a test that provides unambiguous results after 
just two PCR reactions and gel electrophoresis analysis. Hair samples were obtained 
from previously tested NN, NH, and HH horses and their DNA was isolated for PCR. 
Both wild type and mutant specific primer pairs were designed and generated. These 
primer pairs were combined with each of the DNA samples in two different PCR 
reactions, which were analyzed with gel electrophoresis.  
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MATERIALS AND METHODS 
 
Design of Oligonucleotide Primers 
 
 The National Center for Biotechnology Information, or NCBI, website 
(www.ncbi.nlm.nih.gov/) was used to access the horse genome, as well as to locate 
the sodium ion gene, SCN4A. The single nucleotide substitution was identified within 
the genome at nucleotide position 14273176. The region of the gene surrounding this 
mutation was used to design the allele specific oligonucleotide primer pairs, and is 
shown in Figure 3 below.  
 
 
Figure 3: Relevant portion of the Equus caballus gene, SCN4A, which was used to design the allele-
specific oligonucleotide primer pairs to be used in ARMS-PCR. The nucleotide shown in bolded red 
font is the variable nucleotide at position 14273176, which when substituted for guanine, results in 
HYPP. 
 
 
 From this genomic sequence, multiple primer pairs were created using the 
online program, Primer 3 (http://biotools.umassmed.edu/ bioapps/primer3_www.cgi). 
Since the goal of this experiment was to optimize diagnostic ARMS-PCR reactions to 
create a reliable test, multiple allele-specific primer pairs were necessary to ensure 
that the region of interest was amplified with allele-specificity dependent on the 
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primer pair used It was important that the primer pair that was selected for 
optimization was reliable, so having several pairs to choose from allowed for a 
greater pool and a higher likelihood of finding an effective pair.  Primer pairs were 
created with allele-specific upstream primers with common downstream primers as 
well as allele-specific downstream primers with common upstream primers to again 
ensure that the most effective primer pair would be utilized for further optimization. 
The primers created are shown below in Table 2.  
 
 
 
Specificity 
 
Primer 
 
Sequence (5’ 3’) 
Expected 
Product 
Size  
 
WT Specific Upstream HYP_WTU1 CACCGTTGGCTGGAACATCTAC --- 
MUT Specific Upstream HYP_MTU2 CACCGTTGGCTGGAACATCTAG --- 
Common Downstream HYP_D3 TCCAGTGTGTGTGGGTACTGGAA 351 bp 
Common Downstream HYP_D4 ACATGTCCACGCACTTCTCCAGT 428 bp 
Common Downstream HYP_D5 AAAGTGCATAGCACAGCGTCAGG 451 bp 
 
WT Specific Downstream HYP_WTD6 ACAGGATGACAACCACGAAGTGG --- 
MUT Specific Downstream HYP_MTD7 ACAGGATGACAACCACGAAGTGC --- 
Common Upstream HYP_U8 TCCCACCTGTTCATGTCCTGTGT 414 bp 
Common Upstream HYP_U9 TCCCTCTCTCTCTCCCTCTCCTC 482 bp 
Common Upstream HYP_U10 CACCCTGCAACTTCACCACAAAC 397 bp 
Table 2: Sequences of wild type (WT) and mutant (MUT) primers designed and manufactured along 
with expected product size for the different combinations of upstream and downstream primers. The 
primer pairs that were later used for further optimization are shown in bold text.  
 
 
Genomic DNA Isolation 
 
 Three sources of cells were obtained from various horses for isolation and 
purification of DNA: blood, saliva, and hair. This process of isolation was performed 
on each source using different protocols within the Qiagen QIAmp DNA Micro Kit.  
All isolated DNA samples were subjected to Nanodrop quantization to determine 
their nucleic acid concentrations and relative purity (260/280 ratios). This process 
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was done in order to ensure that the DNA was isolated properly and that the sample 
had a high enough concentration of DNA to be an effective template in ARMS-PCR. 
The nucleic acid concentrations of all samples are shown below in Table 3.  
 
Source Designation HYPP Status ng/µL 260/280 
Swab S1 NN 32.1 1.93 
Swab S2 NN 15.0 2.16 
Swab S3 NN 6.3 1.71 
Swab S4 NN 9.6 2.18 
Blood B1 NN 6.4 1.42 
Blood B2 NN 7.2 1.11 
Blood B3 NN 22.5 1.62 
Blood B4 NN 27.3 1.65 
Swab S5 NN 10.9 2.16 
Swab S6 NN 20.9 2.04 
Swab S7 NN 25.3 2.02 
Swab S8 NN 29.1 1.92 
Hair H1 NN 54.0 1.52 
Swab S8 NH 28.4 1.63 
Swab S9 NH 20.4 1.86 
Hair H2 NN 169.9 2.04 
Hair H3 NH 77.3 1.99 
Hair H4 HH 257.4 2.00 
Table 3:  All DNA samples used throughout this experiment, the source that they came from, their 
previously tested HYPP allelic statuses, and their nucleic acid concentrations after isolation. The 
260/280 ratios are also shown, which depicts the protein contamination of the nucleic acid sample, 
depending on its absorbance at 260nm vs. 280nm. NN indicates a wild-type individual, NH indicates a 
carrier for HYPP, and HH indicates an individual with the full-blown disease. The three samples that 
were used to confirm the reliability of the final test are shown in bolded text.  
 
Optimization of Polymerase Chain Reaction 
 
 In order to use PCR as a diagnostic tool, the procedure must be reliable and 
reproducible with the chance of false negatives and false positives minimized. To 
accomplish this, several conditions of the PCR were varied and those that produced 
optimal results were used for the final test. The conditions that were varied 
throughout the optimization process were the primer pairs, the source of DNA 
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samples, the annealing temperature, and the magnesium concentrations within the 
reactions.  
 The first condition varied was the primer pairs. Each primer pair was tested 
with the SNPase PCR kit with 3µL of wild-type DNA, isolated from whole blood. 
The annealing temperature for all initial PCR reactions was set at 55°C and 0.45µL of 
25 mM magnesium chloride was added to enhance the reactions. The primer pair that 
gave the strongest positive result with the wild-type specific primer and a negative 
result with the mutant specific primer was selected for further optimization.  
 Of the three possible DNA sources, hair from horses’ manes was chosen for 
further experimentation. These isolated samples had significantly higher nucleic acid 
concentrations than samples from both blood and saliva, shown in Table 3. Along 
with this quantitative data, this source of genomic DNA was also chosen for practical 
reasons.  Horsehair is very easy to obtain by the horse’s owner, dismissing the need 
for a vet to come out to draw blood, as well as the need to purchase specific supplies, 
such as saliva collection swabs. Horsehair can be pulled by the owner and can be 
stored stably in a plastic bag, which can then be directly sent to a lab for testing. This 
method is the most convenient for horse owners wanting to test their horses, 
eliminates unnecessary intermediate steps, and reduces the cost of obtaining DNA for 
testing.  
 Magnesium concentrations within the PCR reactions were varied 
simultaneously with the annealing temperature throughout a series of PCR runs, again 
in order to optimize the clarity and visibility of positive products and to ensure that 
positive and negative reactions are clearly distinguishable from one another. The 
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annealing temperatures were varied between 50°C and 64°C and 0, 1, or 2µL of 25 
mM MgCl2 were added to various 15µL reactions.  
 
Gel Electrophoresis 
 
 All completed 15µL PCR reactions were combined with 1.5µL of 10X 
Loading Dye.  Each of these 16.5µL mixtures were then loaded into a 1% agarose gel 
in 10X TAE buffer and subjected to approximately 80 Volts of electrical current for 
at least 60-70 minutes.  
 When the PCR bands had migrated through the matrix, the entire gel was 
stained with Ethidium Bromide for 20 minutes and washed with Nanopure distilled 
water. This process allowed for the visualization of the bands formed within the gel 
using a UV Filter in the G:BOX gel documentation system for analysis.  
 
 
Gene Sequencing 
 
 Despite the fact that the PCR products were all around the same size that we 
were expecting, to ensure that the products were in fact corresponding to the region of 
the genome we were intending to amplify, the products were sent out to be sequenced 
(Center for Functional Genomics, SUNY Albany). Two PCR products, one wild type 
and one mutant (from the same heterozygous carrier individual) were cut out of the 
gel, and a Gene Clean Turbo kit (Qbiogene) was used to purify the DNA within them 
and remove any excess nucleotides that may have been present in the reaction after 
PCR.  The DNA sequences were then aligned with the horse genome using BLAT 
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(http://genome.ucsc.edu) to compare the sequence of the PCR products to the 
intended sequence of amplification. 
 
RESULTS AND DISCUSSION 
 
Optimization Analysis 
 
The first step of PCR optimization was to determine which primer pair would 
produce reliable results and would be used in further steps for optimization. The 
primer pairs designed with allele-specific upstream primers and common downstream 
primers were used in 12 separate PCR reactions. Each common downstream primer 
was used with both the wild type and mutant specific upstream primers with DNA 
obtained from both blood and swabs. The DNA samples used in the PCR reactions 
were coded B4 and S1 from Table 3. These 12 PCR reactions were subjected to gel 
electrophoresis, and the ethidium bromide stained gel is shown in Figure 4. This 
analysis showed that of these 12 reactions, the upstream primer HYP_WTU1 
produced strong bands with the common downstream primers HYP_D3 and 
HYP_D4, using wild type DNA from blood, as expected, and both downstream 
primers did not produce bands with the upstream primer HYP_MT2, as intended. 
HYP_WTU1 and HYP_MTU2, each paired with the common downstream primer 
HYP_D3, were chosen for further optimization because these primer pairs not only 
yielded the expected products with DNA obtained from blood, but were also the only 
primer pairs that yielded a visible product with the DNA obtained from swabs, seen 
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in Lane 7 of Figure 4. This suggests that these primer pairs are the most robust with 
various sources of DNA.  
 
 
Figure 4: Gel electrophoretic analysis of 12 PCR reactions using allele-specific upstream primers 
(HYP_WTU1 and HYP_MTU2) with common downstream primers (HYP_D3, HYP_D4, and 
HYP_D5). All PCR products in odd numbered lanes were run with wild type specific primer pairs and 
all products in even numbered lanes were run with mutant specific primer pairs. Lanes 1-6 were run 
with B4 DNA and lanes 7-12 were run with S1 DNA. Lanes 1, 2, 7, and 8 were run using the HYP_D4 
common downstream primer, lanes 3, 4, 9, and 10 were run using the HYP_D5 common downstream 
primer, and lanes 5, 6, 11, and 12 were run using the HYP_D6 common downstream primer.  
 
  
   Kb       1       2        3        4       5       6        7       8       9      10      11     12 
Ladder 
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A similar gel was produced from 12 additional PCR reactions, this time using 
the two allele-specific downstream primers with the three different common upstream 
primers, again with both B4 and S1 DNA. This gel is shown in Figure 5 below. This 
analysis showed that of these 12 PCR reactions and three different common upstream 
primers, only HYP_U8 was able to clearly differentiate between the wild type and 
mutant alleles since it produced a band with HYP_WTD6 and did not produce a band 
with HYP_MTD7, as expected.  However, unlike the previous primer pair chosen 
from Table 2, however, these two primer pairs did not differentiate between the wild 
type allele and mutant allele with the S1 DNA. Therefore, due to this unreliability in 
preliminary testing, the previous primer pairs shown in Table 2, HYP_WTU1 with 
HYP_D3 and HYP_MTU2 with HYP_D3, were used for further optimization.   
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Figure 5: The analysis of 12 PCR reactions using allele-specific downstream primers (HYP_WTD6 
and HYP_MTD7) with common upstream primers (HYP_U8, HYP_U9, and HYP_U10). All PCR 
products in odd numbered lanes were run with wild type specific primer pairs and all products in even 
numbered lanes were run with mutant specific primer pairs. Lanes 1-6 were run with B4 DNA and 
lanes 7-12 were run with S1 DNA. Lanes 1, 2, 7, and 8 were run using the HYP_U8 common upstream 
primer, lanes 3, 4, 9, and 10 were run using the HYP_U9 common upstream primer, and lanes 5, 6, 11, 
and 12 were run using the HYP_U10 common upstream primer. The PCR reaction designated to be 
loaded in Lane 12, (HYP_MTD7 and HYP_U10 with S1 DNA) was not loaded into the gel because 
there was not enough DNA left to have a complete PCR reaction.  
 
 
 
 
 
 Once the allele-specific primer pairs to be used for further optimization were 
chosen, the next experimental condition varied was the annealing temperature of the 
PCR reaction itself. Since the annealing temperature of the preliminary PCR test runs 
for all primer pairs was set at 55°C, a range of 50°C to 60°C was chosen to determine 
  Kb       1       2        3        4       5       6        7       8       9      10      11     12 
Ladder 
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if a higher or lower temperature would produce clearer or a higher yield of products. 
Both the wild type specific primer pair and mutant specific primer pair were run at 
50°C, 55°C, and 60°C with both B4 and S1 DNA. The gel analysis of these PCR 
reactions is shown in Figure 6. Strong bands were produced with the wild type 
specific primer pair at all three temperatures using the DNA isolated from blood, 
however, only one temperature produced a faint band with the wild type primer pair 
and the DNA isolated from swabs. This very faint band can be seen in Lane 11 of 
Figure 6 and was produced by the PCR reaction run at 60°C. This analysis suggested 
that perhaps temperatures 60°C or higher would be most effective for the diagnostic 
test.  
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Figure 6: Gel analysis of various PCR reactions with a temperature gradient of 50°C, 55°C, and 60°C.  
All PCR products in odd lanes were run with the wild type specific primer pair and all PCR products in 
even lanes were run with the mutant specific primer pair.  PCR products in Lanes 1-6 were run with 
DNA B4 and Lanes 7-12 were run with DNA S1. Lanes 1, 2, 7, and 8 were run at 50°C, Lanes 3, 4, 9 
and 10 were run at 55°C, and Lanes 5, 6, 11, and 12 were run at 60°C.  
 
 
 
 Since the PCR reaction run with the DNA isolated from saliva at 60°C 
produced a faint band with the wild type primer pair, further temperature variation 
was done to determine if even higher temperatures would be more optimal. It was 
also decided that a specific Magnesium concentration might also produce a clearer 
product, so this too was varied within the next step of optimization. The gel analysis 
  Kb       1       2        3        4       5       6        7       8       9      10      11     12 
Ladder 
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of the PCR products from these two variations of higher annealing temperatures 
(60°C, 62°C, and 64°C) and amounts of 25 mM magnesium (0 µL, 1 µL, and 2 µL) 
per 15µL reaction are shown below in Figure 7. Since the PCR seemed more robust 
with DNA obtained from blood, only the extremes of each condition were tested as a 
control. The blood DNA was run twice at 60°C with 0µL or 2µL of 25 mM 
magnesium as well as twice at 64°C with 0µL and 2µL, shown in Lanes 1-4.  Since at 
this point, the intention was to optimize PCR for the swab preparations, only the wild 
type primer pairs were used, and all three temperatures were run three times, once 
with each amount of magnesium, 0µL, 1µL, or 2µL.  These nine reactions are shown 
in lanes 5-13. PCR reactions with 2µL of magnesium and DNA from blood produced 
bands at 60°C and 64°C.  The only PCR reactions run with swab DNA that produced 
products were obtained with 1µL of magnesium at either 60°C or 64°C. The former 
band, seen in lane 6 of Figure 7 was the stronger band produced, so these conditions 
of 60°C and 1µL of magnesium were deemed optimal for swab preparations.  
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Figure 7: Gel analysis of various PCR reactions with a temperature gradient of 60°C, 62°C, and 64°C 
as well as the addition of 25 mM magnesium gradient in volumes of 0µL, 1µL, and 2µL.  All lanes 
were run with the wild type primer pair, HYP_WTU1 and HYP_D3.  Lanes 1-4 corresponded to DNA 
isolated from whole blood as controls and lanes 5-12 were run with DNA isolated from swabs. Lanes 
1, 3, 5, 8, and 11 were run with 0µL of magnesium, lanes 2, 4, 7, 10 and 13 were run with 2µL of 
magnesium, and lanes 6, 9, and 12 were run with 1µL of magnesium. For the annealing temperature 
gradient, lanes 1, 2, 5, 6, and 7 were run at 60°C, lanes 3, 4, 11, 12 and 13 were run at 64°C, and lanes 
8, 9 and 10 were fun at 62°C.  
 
 
 
 
 Thus far, the most optimal conditions for wild type DNA obtained from swabs 
with the wild type allele-specific primer pair were 60°C and 1µL of MgCl2 per 15µL 
PCR reaction. Three temperatures at five-degree intervals were tested, however, using 
the optimal 1µL of magnesium, the annealing temperature was again varied in a 
smaller interval of two degrees (58°C, 60°C, 62°C, and 64°C). During this 
optimization step, the mutant primer pair was also used with each set of conditions to 
  Kb       1       2        3        4       5       6        7       8       9      10      11     12      13 
Ladder 
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ensure that the PCR was still stringent enough to produce differentiated results among 
alleles. The analyses of these experimental reactions are shown in Figure 8. PCR 
reactions run at all four temperatures produced bands with the wild type primer pair, 
and did not yield products with the mutant primer pair, as expected.  Since the 60°C 
reaction was consistent from the previous optimization experiment and was proven to 
differentiate the wild type allele from the mutant allele effectively, this temperature 
was used for future experimental tests.  
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Figure 8: Gel analysis of eight PCR reactions with an annealing temperature gradient of 58°C, 60°C, 
62°C, and 64°C. All PCR reactions were run with DNA isolated from wild-type swabs and with 1 µL 
of 25 mM magnesium. All odd lanes were run with the wild type primer pair and all even lanes were 
run with the mutant primer pair. Lanes 1 and 2 were run at 58°C, lanes 3 and 4 were run at 60°C, lanes 
5 and 6 were run at 62°C, and lanes 7 and 8 were run at 64°C.  
 
 
 At this point of the experimental process, horsehair was available for DNA 
isolation and optimization, as this was chosen to be the preferred method of obtaining 
DNA for testing due to its convenience to owners and high nucleic acid concentration 
after isolation. Using the optimal conditions for swab preparations as a starting point, 
the annealing temperature was again varied by a two degree interval of 60°C, 62°C 
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and 64°C with both primer pairs and wild type DNA obtained from horsehair. As 
what was found to be optimal for the PCR reactions with DNA obtained from swabs, 
1µL of 25 mM magnesium was added to each reaction. The gel analysis of these six 
reactions can be seen below in Figure 9.  PCR reactions run with the wild type primer 
pair at all three temperatures produced clear bands and PCR reactions run with the 
mutant primer pair at all three temperatures did not yield products, as intended.  Since 
the reaction run at 60°C distinguished allelic genotype with all three genomic DNA 
isolations, produced unambiguous differentiation between the wild type and mutant 
products, and therefore seemed to be the most robust, it was decided that this 
temperature would be used for the final protocol.  
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Figure 9: Gel analysis of a six PCR reactions with an annealing temperature gradient of 60°C, 62°C, 
and 64°C with DNA isolated from wild-type horsehair. All odd lanes were run with the wild type 
primer pair and all even lanes were run with the mutant primer pair. Reactions in lanes 1 and 2 were 
run at 60°C, lanes 3 and 4 were run at 62°C, and lanes 5 and 6 were run at 64C.  
 
 
 
Confirmation of Final Protocol 
 
  
 From the optimization experiments, it was determined that with DNA isolated 
from wild type horsehair, an annealing temperature of 60°C and the addition of 1µL 
of 25 mM magnesium would produce the most optimal product yield when the PCR 
was run with the wild type primer pair and would not produce any significant product 
when the PCR was run with the mutant primer pair. This type of unambiguous result 
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was what was desired at the start of my experiments in coming up with a reliable and 
robust diagnostic test. The next step, however, was to be sure that these conditions 
would be just as effective with mutant or carrier DNA. The mutant primer pair had 
not yet been tested with a mutant allele. For this reason, horsehair from mutant and 
carrier individuals were obtained and DNA was isolated so that it could be 
demonstrated that the mutant-specific primer pair also worked effectively and under 
appropriate conditions.  
 Eight PCR reactions were run with four different DNA samples. B4 was used 
as a wild type control, since the DNA samples obtained from blood had seemed to 
yield the strongest product under various conditions. Wild type, carrier, and mutant 
DNA, H2, H3, and H4 from Table 3, respectively, were used to confirm that the 
conditions of the designed test were reliable for all HYPP allelic conditions. Each 
DNA sample was subjected to two PCR reactions: one with the wild type primer pair, 
and one with the mutant primer pair. These PCR reactions were run at 60°C with 1µL 
of 25 mM magnesium, and their analysis can be seen below in Figure 10. As seen in 
the gel, both wild type DNA samples only yielded PCR products with the wild type 
specific primer pair, the carrier DNA sample yielded PCR products with both primer 
pairs, suggesting that that DNA sample contained both alleles of the gene, and the 
mutant DNA sample yielded a PCR product only with the mutant specific primer pair. 
This experimental step was essential in showing that the protocol for this diagnostic 
test was in fact robust, reliable, and unambiguous.  
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Figure 10: Gel analysis of eight PCR reactions using the final protocol conditions. All odd numbered 
lanes were run with the wild type specific primer pair and all even numbered lanes were run with the 
mutant specific primer pair. Lanes 1 and 2 were run with B4 DNA as a control, lanes 3 and 4 were run 
with H2 DNA (N/N), lanes 5 and 6 were run with H3 DNA (N/H) and lanes 7 and 8 were run with H4 
DNA (H/H). All reactions were run with 1 µL of 25 mM magnesium and at an annealing temperature 
of 60°C.  
 
 
 
Sequencing Analysis 
 
 
 Although my final diagnostic test was shown to reliably differentiate between 
HYPP allelic statuses of the several DNA samples used for experimentation, wild 
type DNA from one of the PCR products was isolated and sent out for sequencing to 
ensure that the PCR reactions were amplifying the intended region of the genome.  
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The results of this sequencing were then aligned with the horse genome using BLAT, 
as shown in Figure 11 below. This alignment located the sequence of the PCR 
product to that portion of Chromosome 11 corresponding to the SCN4A gene locus, as 
intended. The sequenced product was 99.7% homologous to the desired region of the 
genome. This 0.3% difference was likely due to sequencing errors. These results 
conform that the PCR reactions were amplifying the intended region of the genome.  
 
Figure 11: This figure shows the BLAT sequence alignment with the SCN4A gene from the horse 
genome to the sequence of the HYPP PCR product amplified from carrier horsehair DNA  
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Comparison to Current Test 
 
 
 In 1996, the AQHA ruled that all descendents of Impressive foaled after 
January 1, 1998 must be tested and must have his or her HYPP status disclosed on the 
registration certificate (www.aqha.com). Currently, the American Quarter Horse 
Association will accept HYPP test results from eight licensed laboratories. Dr. Sharon 
Spier was one of the main researchers at UC Davis to come up with the test currently 
in use.  This current test involves a process of DNA isolation, PCR, gel 
electrophoresis, allele-specific oligonucleotide hybridization, duplicate filtering 
processes, autoradiography, and analysis (Rojas et al., 1991; Rudolph et al., 1992).  
In comparison to the test designed from this research, this current test is much less 
efficient.  While the current test could take a matter of three to four days, this new test 
can be done in less than one day. While the allele-specificity of the current test lies 
within the oligonucleotide hybridization, or the fourth step of the process, the allelic 
specificity of this new test is present in the second step of the ARMS-PCR procedure 
I developed.  This allows for more accurate results by minimizing unnecessary steps 
that may go wrong, producing false positive or false negative results. By minimizing 
these steps, the new test also minimizes materials and time needed, thus increasing 
the efficiency of time and money. Finally, this new test has been shown to be reliable 
and accurate with several different DNA samples, confirming its robust properties.  
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